Overview
ProtonDx develops portable point-of-care molecular diagnostic platforms like Dragonfly for rapid detection of viral and bacterial pathogens in human and animal health, delivering PCR-quality results in under 30 minutes without lab infrastructure. Their Research Use Only (RUO) products support customizable testing for diseases including COVID-19, malaria, mpox, influenza, and veterinary pathogens like APP and GPS. Solutions include isothermal amplification, nucleic acid extraction kits, and multiplex assays adaptable for life sciences research, agriculture, and global health applications.
Frequently asked questions
- What diagnostic platforms and capabilities does ProtonDx offer?
- ProtonDx offers the Dragonfly portable molecular diagnostic platform using isothermal amplification (LyoLAMP) for multiplex detection of up to six pathogens in under 30 minutes, plus SmartLid nucleic acid extraction kits for human, animal, and research applications.
- What regulatory status apply to ProtonDx products?
- Products are primarily Research Use Only (RUO) for research applications, with portable systems intended for use by trained operators, not self-testing; some assays support clinical decision-making in research settings.
- What geographies and sectors does ProtonDx serve?
- ProtonDx serves global markets including human health, animal agriculture, veterinary, life sciences, and food safety, with deployments in extreme conditions worldwide and partnerships for custom solutions in pharma, farms, and remote care.